Loading...
Price History
Market Data
| Market Cap | 169.91B |
| P/E Ratio | - |
| P/B Ratio | 70.77 |
| EPS | -1.10 |
| Dividend Yield | - |
| D/E Ratio | 1.44 |
| Current Ratio | 2.43 |
| Currency | USD |
Key Financial Metrics
3.25B
Revenue
-207.95M
Net Income
-1.10
EPS (Diluted)
402.73M
Free Cash Flow
Profitability
Gross Margin
69.7%
Operating Margin
-6.4%
Net Profit Margin
-6.4%
EBITDA
-206.30M
Returns & Efficiency
Return on Assets (ROA)
-3.5%
Return on Equity (ROE)
-8.7%
Dividend Yield
-
EPS
-1.10
Financial Health
Total Assets
5.86B
Total Debt
-
Debt to Equity
1.44x
Current Ratio
2.43
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Health Services |
| HQ | MADISON, WI |
| Fiscal Year | 2025 |
Peers
NATERA, INC.
NTRA
30.80B
P/E: --
21.15B
P/E: --
21.15B
P/E: --
20.89B
P/E: --
12.16B
P/E: --
12.16B
P/E: --
CELCUITY INC.
CELC
6.71B
P/E: --
5.40B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$169.91B
P/E Ratio (TTM)-
Price to Book70.77
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin69.7%
Operating Margin-6.4%
Net Margin-6.4%
ROE-8.7%
ROA-3.5%
Leverage & Liquidity
Debt to Equity1.44
Current Ratio2.43
Total Debt-
Total Assets$5.86B
Stockholders' Equity$2.40B
Income Statement (FY 2025)
Revenue$3.25B
Gross Profit$2.26B
Operating Income$-206.30M
Net Income$-207.95M
EPS (Diluted)$-1.10
Cash Flow (FY 2025)
Free Cash Flow$402.73M
Cash & Equivalents$956.00M
Revenue Growth17.7%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 5505 ENDEAVOR LANE MADISON, WI 53719 |
| Phone | 608-284-5700 |
| Incorporated | None, None |
| EIN | 200478229 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 190.89M |
| Stockholders' Equity | $2.40B |
| Cash & Equivalents | $956.00M |
Recent Filings
View All
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-03-26
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-02-17
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-13
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2026-02-13
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-13
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-02-10
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-03
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-01
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-04-29
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-02-19
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-05
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | EXACT SCIENCES CORP |
| Ticker | EXAS |
| Exchange | -- |
| Sector | Services |
| Industry | Health Services |
| Headquarters | MADISON, WI |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 169.91B |
| Revenue | 3.25B |
| Net Income | -207.95M |
| P/E Ratio | - |
| EPS | -1.10 |
| Net Margin | -6.4% |
| ROE | -8.7% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...